Speakers from leading institutions and organizations discuss the current state of precision medicine, the effective models they use in their research, and the future applications.
Cytiva’s brand new single-use production facility in Wales, UK, forms part of Cytiva’s >$1.5 billion investment in increased capacity to support the growing needs of the biopharmaceutical industry and to increase regional supply.
Learn more about cold chain tubing and containers designed for cryogenic storage and transport applications enabling closed-system continuous processing.
Germfree’s bioGO® Mobile Biocontainment Laboratories offer the ideal solution for providing surge capacity for laboratory services. By utilizing a fully equipped/turnkey Mobile Biocontainment Laboratory, facilities are able to rapidly increase their volume without sacrificing capabilities.
Celsius FFT | FFTp with Safecore Technology is a single-use sterile and pre-assembled container with an innovative bag-in-plate design (cassette) for exceptional protection during frozen storage, handling and shipping of biopharmaceutical products.
Explore connectors with a nominal 1 ½” flow path that enables quick and easy sterile connections, in large-volume, high-flow production and process intensification environments.
Discover the benefits of a best-in-class Quality Management System, a global GMP Depot Network, Direct-to/From-Patient, Home Healthcare nursing services, and industry-leading expertise all under one single-source provider.
The global shortage of transplantable organs is considered one of the greatest modern medical crises. XT-ViVo® & TimeSeal® will enable multi-day preservation and remove time from the equation.
Single-Use GORE STA-PURE Flexible Freeze Containers are intended for handling, transport and storage of frozen bulk drug substances, after freezing at -86°C (-123°F). They resist cracks, breaks, or leaks if accidentally dropped.
Cryoport’s new Advanced Therapy Shipper™ (ATS) product line, a first-of-its-kind fleet, contains shippers dedicated exclusively to cell and gene supply chain management for both clinical and commercial therapies.
Ensure our newsletter reaches your inbox by following these whitelist instructions.
This newsletter is being sent to {{lead.Email Address}}. If you need to update
your
preferences, please visit your user profile. To cancel your subscription to the newsletter,
please opt out.
This website uses cookies to ensure you get the best experience on our website. Learn more